Advisor Group’s Zymeworks ZYME Stock Holding History

Advisor Group’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$10K	Sell	227 -1,081	-83%	-$39.3K	﹤0.01%	4378
2019 Q3	$32K	Sell	1,308 -498	-28%	-$12.5K	﹤0.01%	3694
2019 Q2	$40K	Buy	1,806 +540	+43%	+$9.91K	﹤0.01%	3531
2019 Q1	$21K	Sell	1,266 -150	-11%	-$2.33K	﹤0.01%	3958
2018 Q4	$21K	Hold	1,416	–	–	﹤0.01%	3784
2018 Q3	$22K	Buy	1,416 +277	+24%	+$3.96K	﹤0.01%	3846
2018 Q2	$17K	Buy	1,139 +159	+16%	+$2.46K	﹤0.01%	3815
2018 Q1	$12K	Buy	980 +680	+227%	+$7.36K	﹤0.01%	3989
2017 Q4	$2K	Buy	+300	New	+$2.47K	﹤0.01%	4723

Other funds holding ZYME

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Advisor Group's ZYME Position: Q4 2019 in Review

Advisor Group reduced its Zymeworks (ZYME) stake by 83% in Q4 2019, selling an estimated $39.3K and leaving 227 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #4378.

Advisor Group first reported a position in ZYME in Q4 2017 and has held it in 9 quarters since. The position peaked at $40K in Q2 2019. 103 funds tracked by Wall St. Rank hold ZYME as of Q4 2019.

Advisor Group held 227 shares of Zymeworks worth $10K as of Q4 2019.
Advisor Group sold 1,081 Zymeworks shares in Q4 2019, an estimated $39.3K.
Zymeworks made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4378 holding.
Advisor Group first reported a position in Zymeworks in Q4 2017 and has held it in 9 quarters since.
Advisor Group's Zymeworks position peaked at $40K in Q2 2019.
103 funds tracked by Wall St. Rank held Zymeworks as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.